Nath Bio-Genes (I) logo

NATHBIOGEN - Nath Bio-Genes (I) Share Price

₹413.65 -5.7  -1.4%

Last Trade - 11:29am

Consumer Defensives
Small Cap
Market Cap £77.8m
Enterprise Value £83.5m
Revenue £30.5m
Position in Universe 996th / 3121
Unlock NATHBIOGEN Revenue
Relative Strength (%)
1m -5.09%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -11.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
1,853 1,621 1,697 1,917 2,309 2,799 3,331 3,830 +8.6%
+4.5 -44.2 +15.0 +75.4 +13.2 +31.2 +12.5 +12.9
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, NathBio-Genes (I) Ltd revenues increased 15% to RS2.53B. Netincome applicable to common stockholders increased 13% toRS485.2M. Revenues reflect an increase in demand for theCompany's products and services due to favorable marketconditions. Net income was partially offset by Selling andDistribution expenses increase of 10% to RS530.6M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History



Net Income


Normalised EPS


PE Ratio Range


Dividend Yield Range

NATHBIOGEN Dividend Yield Range Unlock NATHBIOGEN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
Profile Summary

Nath Bio-Genes (India) Limited is engaged in hybrid seed business. The Company is engaged in the business of production, processing and marketing of hybrid and genetically modified (GM) seeds. The Company’s segments include agricultural activities (seed production) and trading activities. Its products include field crops, cereals, fibre and oil seeds, vegetable crops and micro nutrient supplements. Its cereals range includes maize, paddy, pearl millet, wheat and jowar. It offers fiber and oils seeds, such as cotton, mustard and sunflower. Its nutritional supplements include Win-Chi-Win and Bio-Energy. Its vegetable crop range includes chilli, okra, tomato, bottle gourd, bitter gourd, cucumber and coriander. The Company has seed processing facilities with approximately 10 processing plants located in Maharashtra and Andhra Pradesh. It also has processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh and Rajasthan on custom basis.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated July 14, 1993
Public Since January 28, 2014
No. of Shareholders: 95
No. of Employees: n/a
Sector Consumer Defensives
Industry Food & Tobacco
Exchange National Stock Exchange of India
Shares in Issue 19,004,000
Free Float (0.0%)
Eligible for
NATHBIOGEN Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for NATHBIOGEN
Upcoming Events for NATHBIOGEN
Friday 23rd July, 2021 Estimate
Nath Bio-Genes (I) Ltd Annual Shareholders Meeting
Frequently Asked Questions for Nath Bio-Genes (I)
What is the Nath Bio-Genes (I) share price?

As of 11:29am, shares in Nath Bio-Genes (I) are trading at ₹413.65, giving the company a market capitalisation of £77.8m. This share price information is delayed by 15 minutes.

How has the Nath Bio-Genes (I) share price performed this year?

Shares in Nath Bio-Genes (I) are currently trading at ₹413.65 and the price has moved by 22.56% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Nath Bio-Genes (I) price has moved by -24.13% over the past year.

What are the analyst and broker recommendations for Nath Bio-Genes (I)?

There are no analysts currently covering Nath Bio-Genes (I).

When will Nath Bio-Genes (I) next release its financial results?

Nath Bio-Genes (I) is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Nath Bio-Genes (I) dividend yield?

Nath Bio-Genes (I) does not currently pay a dividend.

Does Nath Bio-Genes (I) pay a dividend?

Nath Bio-Genes (I) does not currently pay a dividend.

When does Nath Bio-Genes (I) next pay dividends?

Nath Bio-Genes (I) does not currently pay a dividend.

How do I buy Nath Bio-Genes (I) shares?

To buy shares in Nath Bio-Genes (I) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Nath Bio-Genes (I)?

Shares in Nath Bio-Genes (I) are currently trading at ₹413.65, giving the company a market capitalisation of £77.8m.

Where are Nath Bio-Genes (I) shares listed? Where are Nath Bio-Genes (I) shares listed?

Here are the trading details for Nath Bio-Genes (I):

Country of listing: India
Exchange: NSI
Ticker Symbol: NATHBIOGEN
What kind of share is Nath Bio-Genes (I)?

Based on an overall assessment of its quality, value and momentum, Nath Bio-Genes (I) is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Nath Bio-Genes (I) share price forecast 2021?

We were not able to load any forecast data for Nath Bio-Genes (I).

How can I tell whether the Nath Bio-Genes (I) share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nath Bio-Genes (I). Over the past six months, the relative strength of its shares against the market has been 25.39%. At the current price of ₹413.65, shares in Nath Bio-Genes (I) are trading at 34.57% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Nath Bio-Genes (I) PE Ratio?

The Nath Bio-Genes (I) PE ratio based on its reported earnings over the past 12 months is 14.19. The shares are currently trading at ₹413.65.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Nath Bio-Genes (I)?

Nath Bio-Genes (I)'s management team is headed by:

Sweta Kagliwal - NED
Satish Kagliwal - MDR
Shrirang Agrawal - NED
Kashinath Iyer - IND
Devinder Khurana - CFO
Dhiraj Rathi - CCO
Jeevanlata Kagliwal - DRC
Ashu Jain - IND
Who are the major shareholders of Nath Bio-Genes (I)?

Here are the top five shareholders of Nath Bio-Genes (I) based on the size of their shareholding:

Authum Investments and Infrastructure Ltd. Investment Advisor
Percentage owned: 15.8% (3.00m shares)
Ashu Farms Pvt. Ltd. Corporation
Percentage owned: 10.99% (2.09m shares)
Akash Farms Pvt. Ltd. Corporation
Percentage owned: 10.75% (2.04m shares)
Aditya Birla Sun Life AMC Limited Investment Advisor
Percentage owned: 8.53% (1.62m shares)
Agri- Tech (India) Ltd. Corporation
Percentage owned: 6.93% (1.32m shares)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.